Results 21 to 30 of about 39,119 (216)
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source
Supra and subgingival application of antiseptics or antibiotics during periodontal therapy
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases (gingivitis and periodontitis) are characterized by inflammatory processes which arise as a result of disruption of the balance in the oral ecosystem. According to the current S3 level clinical practice guidelines, therapy of patients with periodontitis involves a stepwise approach that includes the control of the patient ...
Elena Figuero +5 more
wiley +1 more source
Медицинский совет, 2013 The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
A. I. Sinopalnikov
doaj +1 more source
Pharmacological Reports, 2020 A large body of research has focused on fluoroquinolones. It was shown that this class of synthetic antibiotics could possess antiviral activity as a broad range of anti-infective activities.
Krzysztof Marciniec +4 more
semanticscholar +1 more source
Nanomaterials, 2022 The current study delineates the use of date-palm-derived cellulose nanocrystals (dp-CNCs) as reinforcing agents. dp-CNCs were incorporated in varying amounts to poly(vinyl alcohol)/guar-gum-based phase-separated composite films.
Hamid M. Shaikh +4 more
doaj +1 more source
Annals of Clinical Microbiology and Antimicrobials, 2010 Introduction Antibiotic resistance decreases success of Helicobacter pylori (Hp) eradication. Recently published results show low rate of resistance and better compliance with moxifloxacin based regiments.
Tomić Monika +7 more
doaj +1 more source
Moxifloxacin-induced neutropenia in 26-year-old man
Journal of Infection in Developing Countries, 2018 Moxifloxacin is a fourth generation widely used fluoroquinolone antibiotic. There are three cases of moxifloxacin-induced neutropenia reported in the literature and we report the fourth case.
Tuğba Kula Atik +6 more
doaj +1 more source
Fluoroquinolones’ Biological Activities against Laboratory Microbes and Cancer Cell Lines
Molecules, 2022 Development of novel derivatives to rein in and fight bacteria have never been more demanding, as microbial resistance strains are alarmingly increasing.
Ghadeer A. R. Y. Suaifan +2 more
doaj +1 more source
Microorganisms, 2022 When faced with nutritional deprivation, bacteria undergo a range of metabolic, regulatory, and biosynthetic changes. Those adjustments, which can be specific or independent of the missing nutrient, often alter bacterial tolerance to antibiotics.
Annabel S. Lemma +2 more
doaj +1 more source
AAPS PharmSciTech, 2020 The objectives of the present research work were systematic development of novel in situ gel formulation containing nanoparticles for localised delivery of moxifloxacin against bacterial periodontitis.
S. Beg +6 more
semanticscholar +1 more source